相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protocol for colitis-associated colorectal cancer murine model induced by AOM and DSS
Wenbo Sun et al.
STAR PROTOCOLS (2023)
Palladium catalyzed migratory heck coupling of arteannuin B and boronic acids: An approach towards the synthesis of antiproliferative agents in breast and lung cancer cells
Majeed Shaikh et al.
BIOORGANIC CHEMISTRY (2022)
β-(4-fluorobenzyl) Arteannuin B induced interaction of ATF-4 and C/EBPβ mediates the transition of breast cancer cells from autophagy to senescence
Khalid Bashir Mir et al.
FRONTIERS IN ONCOLOGY (2022)
Rottlerin promotes anti-metastatic events by ameliorating pharmacological parameters of paclitaxel: An in-vivo investigation in the orthotopic mouse model of breast cancer
Diksha Manhas et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2022)
Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis
Mengxia Wang et al.
FRONTIERS IN PHARMACOLOGY (2021)
Intramolecular oxidative rearrangement: I2/TBHP/DMSO-mediated metal free facile access to quinoxalinone derivatives
Nancy Slathia et al.
TETRAHEDRON LETTERS (2021)
Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease
Maria I. Avrutsky et al.
FRONTIERS IN PHARMACOLOGY (2021)
Targeting apoptosis in cancer therapy
Benedito A. Carneiro et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Malononitrile-activated synthesis and anti-cholinesterase activity of styrylquinoxalin-2(1H)-ones
Sheena Mahajan et al.
RSC ADVANCES (2020)
Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors
Yunpeng Ji et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer
Qiang He et al.
CANCER LETTERS (2019)
Quinoxaline-PABA bipartite hybrid derivatization approach: Design and search for antimicrobial agents
Harun M. Patel et al.
JOURNAL OF MOLECULAR STRUCTURE (2019)
Analysis of the Mitochondrial Membrane Potential Using the Cationic JC-1 Dye as a Sensitive Fluorescent Probe
Farzane Sivandzade et al.
BIO-PROTOCOL (2019)
Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics
Rehmat Jan et al.
ADVANCED PHARMACEUTICAL BULLETIN (2019)
Roles of ERK1/2 and PI3K/AKT signaling pathways in mitochondria-mediated apoptosis in testes of hypothyroid rats
Yueli Yao et al.
TOXICOLOGY RESEARCH (2018)
Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and - Intrinsic Activities
Erin E. Talbert et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Targeting cancer cell mitochondria as a therapeutic approach: recent updates
Qingbin Cui et al.
FUTURE MEDICINAL CHEMISTRY (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase
Hebat-Allah S. Abbas et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
First-In-Class Small Molecule ONC201 Induces DR5 and Cell Death in Tumor but Not Normal Cells to Provide a Wide Therapeutic Index as an Anti-Cancer Agent
Joshua E. Allen et al.
PLOS ONE (2015)
Crystal structure refinement with SHELXL
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY (2015)
Design, synthesis and pharmacological evaluation of novel pyrrolizine derivatives as potential anticancer agents
Ahmed M. Gouda et al.
BIOORGANIC CHEMISTRY (2014)
Structure-activity relationships studies of quinoxalinone derivatives as aldose reductase inhibitors
Saghir Hussain et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Pyrrolizidine alkaloids
Jeremy Robertson et al.
NATURAL PRODUCT REPORTS (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Functions and regulation of the PTEN gene in colorectal cancer
Francesca Molinari et al.
FRONTIERS IN ONCOLOGY (2014)
Osthole Exhibits Anti-Cancer Property in Rat Glioma Cells Through Inhibiting PI3K/Akt and MAPK Signaling Pathways
Daofang Ding et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Cell Survival and Apoptosis Signaling as Therapeutic Target for Cancer: Marine Bioactive Compounds
Senthilkumar Kalimuthu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Discovery and Optimization of a Series of 3-(3-Phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: Orally Bioavailable, Selective, and Potent ATP-Independent Akt Inhibitors
Mark A. Ashwell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
PTEN regulation of ERK1/2 signaling in cancer
Mahandranauth A. Chetram et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2012)
Hepatotoxicity and Tumorigenicity Induced by Metabolic Activation of Pyrrolizidine Alkaloids in Herbs
Na Li et al.
CURRENT DRUG METABOLISM (2011)
Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent
Malleshappa N. Noolvi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Apoptosis in cancer: from pathogenesis to treatment
Rebecca S. Y. Wong
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
Design, synthesis and preliminary evaluation of some novel [1,4]diazepino [5,6-b]pyrrolizine and 6-(2-oxopyrrolidino)-1H-pyrrolizine derivatives as anticonvulsant agents
Safinaz E. Abbas et al.
MEDICINAL CHEMISTRY RESEARCH (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Apoptosis Induction by MEK Inhibition in Human Lung Cancer Cells Is Mediated by Bim
Jieru Meng et al.
PLOS ONE (2010)
Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition
Wen-I Wu et al.
PLOS ONE (2010)
PTEN and the PI3-Kinase Pathway in Cancer
Nader Chalhoub et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
OLEX2: a complete structure solution, refinement and analysis program
Oleg V. Dolomanov et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
The role of PTEN signaling perturbations in cancer and in targeted therapy
M. Keniry et al.
ONCOGENE (2008)
A short history of SHELX
George M. Sheldrick
ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES (2008)
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
James A. McCubrey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
P. J. Roberts et al.
ONCOGENE (2007)
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
Lao H. Saal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistance
S McKenzie et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Oncogenes and tumor suppressor genes in breast cancer: Potential diagnostic and therapeutic applications
C Osborne et al.
ONCOLOGIST (2004)
Genotoxic Pyrrolizidine Alkaloids - Mechanisms Leading to DNA Adduct Formation and Tumorigenicity
Peter P. Fu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2002)
Antimicrobial activity of pyrrolizidine alkaloids from Heliotropium subulatum
B Singh et al.
FITOTERAPIA (2002)
The Raf/MEK/ERK pathway:: new concepts of activation
C Peyssonnaux et al.
BIOLOGY OF THE CELL (2001)
分享论文
